White label – Pompe disease - ClinicalTrials.eu

Study of Venetoclax and Azacitidine for Maintenance Therapy in Patients with Acute Myeloid Leukemia in First Remission After Chemotherapy

Not recruiting

3 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia (in remission)
Investigated Drugs:
- Azacitidine
- Venetoclax
+1
Study on Atezolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer with Positive ctDNA After Surgery

Not recruiting

3 1 1
Investigated Drugs:
- Atezolizumab
+3
Study on the Safety and Effects of THOR-707 and Drug Combination in Adults with Advanced or Metastatic Cancer

Not recruiting

1 1 1 1
Investigated Diseases:
- Metastasis
Investigated Drugs:
Study on the Safety and Tolerability of Abelacimab Compared to Rivaroxaban in Patients with Atrial Fibrillation

Not recruiting

2 1 1 1
Investigated Drugs:
- Rivaroxaban
- Abelacimab
Study on the Safety and Pharmacokinetics of Risdiplam in Infants with Spinal Muscular Atrophy

Not recruiting

2 1 1 1
Investigated Diseases:
- Spinal muscular atrophy
Investigated Drugs:
- Risdiplam
Long-term Study on the Safety and Effectiveness of Odevixibat for Patients with Alagille Syndrome

Not recruiting

3 1 1 1
Investigated Drugs:
- Odevixibat
Study on the Effects of Pariglasgene Brecaparvovec for Adults with Glycogen Storage Disease Type Ia

Not recruiting

1 1 1
Investigated Diseases:
- Glycogen storage disease type I
Investigated Drugs:
- Pariglasgene Brecaparvovec
Study of TransCon TLR7/8 Agonist, TransCon IL-2 β/γ, and Pembrolizumab for Patients with Advanced Head and Neck Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Squamous cell carcinoma of head and neck
Investigated Drugs:
Study on Siplizumab and Rabbit Anti-Thymocyte Globulin for Preventing Rejection in New Kidney Transplant Patients

Not recruiting

2 1 1 1
Investigated Drugs:
Study Comparing Polatuzumab Vedotin with Rituximab, Ifosfamide, Carboplatin, and Etoposide for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies